41. Performance of timing Resistive Plate Chambers with protons from 200 to 800 MeV. (27th January 2015) Authors: Machado, J.; Adamczewski-Musch, J.; Blanco, A.; Boretzky, K.; Cabanelas, P.; Cartegni, L.; Marques, R. Ferreira; Fonte, P.; Fruehauf, J.; Galaviz, D.; Heil, M.; Henriques, A.; .Ickert, G; Körper, D.; Lopes, L.; Palka, M.; Pereira, A.; Rossi, D.; Simon, H.; Teubig, P. Journal: Journal of instrumentation Issue: Volume 10:Number 1(2015:Jan.) Page Start: C01043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Performance of timing resistive plate chambers with relativistic neutrons from 300 to 1500 MeV. (18th February 2015) Authors: Blanco, A.; Adamczewski-Musch, J.; Boretzky, K.; Cabanelas, P.; Cartegni, L.; Marques, R. Ferreira; Fonte, P.; Fruehauf, J.; Galaviz, D.; Heil, M.; Henriques, A.; Ickert, G.; Körper, D.; Lopes, L.; Palka, M.; Pereira, A.; Rossi, D.; Simon, H.; Teubig, P.; Traxler, M. Journal: Journal of instrumentation Issue: Volume 10:Number 2(2015:Feb.) Page Start: C02034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors. (October 2022) Authors: Arribas, A.; Vultaggio, S.; Andronache, A.; Robusto, M.; Fancelli, D.; Cannas, E.; Spriano, F.; Tarantelli, C.; Rossi, D.; Zucca, E.; Stathis, A.; Varasi, M.; Mercurio, C.; Bertoni, F. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38). (17th June 2021) Authors: Pirosa, M. C.; Orsucci, L.; Feugier, P.; Tani, M.; Ghesquieres, Hervé; Musuraca, G.; Baldini, L.; Merli, F.; De Renzis, B.; Gyan, E.; Gini, G.; Marino, D.; Gressin, R.; Morschhauser, F.; Palombi, F.; Cavallo, F.; Conconi, A.; Le Gouill, S.; Tilly, Hervé; Zanni, M. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. PQR309, idelalisib, duvelisib and ibrutinib lead to similar gene expression changes in activated B-cell like (ABC) diffuse large B-cell lymphoma (DLBCL). (December 2016) Authors: Arribas, A.; Rinaldi, A.; Spriano, F.; Tarantelli, C.; Gaudio, E.; Bernasconi, E.; Hillmann, P.; Kwee, I.; Stathis, A.; Fabbro, D.; Stüssi, G.; Zucca, E.; Rossi, D.; Cmiljanovic, V.; Bertoni, F. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. S136: CONSTITUTIVE VLA-4 ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. THE OTHER SIDE OF BCR AUTONOMOUS SIGNALING. (23rd June 2022) Authors: Tissino, E.; Bomben, R.; Maity, P. C.; Pozzo, F.; Forestieri, G.; Nicolò, A.; Härzschel, A.; Bittolo, T.; Rossi, F. M.; Datta, M.; Zaja, F.; Capasso, G.; D'Arena, G.; Chiarenza, A.; Di Raimondo, F.; Jumaa, H.; Rossi, D.; Del Poeta, G.; Hartmann, T. N.; Zucchetto, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA. (23rd June 2022) Authors: Pirosa, M. C.; Bruscaggin, A.; Terzi di Bergamo, L.; Salehi, M.; Pini, K.; Spina, V.; Bocchetta, S.; Condoluci, A.; Forestieri, G.; Piffaretti, D.; Marques De Almeida, J.; Annunziata, S.; Bergesio, F.; Borsatti, E.; Bulian, P.; Chauvie, S.; Marco, C.; Martina, D. T.; Bernhard, G.; Kurlapski, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019) Authors: Stathis, A.; Mey, U.; Schär, S.; Hitz, F.; Pott, C.; Mach, N.; Krasniqi, F.; Novak, U.; Schmidt, C.; Hohloch, K.; Kienle, D.; Hess, D.; Moccia, A.; Unterhalt, M.; Eckhardt, K.; Hayoz, S.; Rossi, D.; Dirnhofer, S.; Ceriani, L.; Bertoni, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. SAT0061 Concurrent Ultrasound-Detected Synovitis and Tenosynovitis Predict Flare in Patients with Rheumatoid Arthritis in Clinical Remission. (15th July 2016) Authors: Sakellariou, G.; Bellis, E.; Scirè, C.A.; Carrara, G.; Adinolfi, A.; Bortoluzzi, A.; Batticciotto, A.; Cagnotto, G.; Caprioli, M.; Canzoni, M.; Cavatorta, F.P.; De Lucia, O.; Di Sabatino, V.; Draghessi, A.; Filippou, G.; Farina, I.; Focherini, M.C.; Gabba, A.; Gutierrez, M.; Idolazzi, L. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. SAT0122 Reduction of Peripheral Blood G-Ifn and IL-17 Producing T Cells After Therapy with Abatacept for Rheumatoid Arthritis. (23rd January 2014) Authors: Scarsi, M.; Zanotti, C.; Chiarini, M.; Piantoni, S.; Imberti, L.; Frassi, M.; Bosio, C.; Rossi, D.; Paletti, A.; Tincani, A.; Airò, P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗